calcium sodium transport process patient cystic fibrosi specif decreas mg2depend ca2adenosin triphosphatas activ erythrocyt membran cystic fibrosi patient calciumatpas activ mg2depend ca2atpas atp phosphohydrolas ec 3613 erythrocyt membran prepar cystic fibrosi cf patient wa greatli reduc compar erythrocyt membran control subject km calcium wa found similar two group howev vmax maxim rate activ ca2atpas reduc 50 erythrocyt membran prepar cf patient p less 0001 contrast mg2atpas activ erythrocyt membran cf patient wa unchang compar control subject differ nakatpas activ erythrocyt membran cf patient compar control patient could observ thi indic ca2atpas activ note cf erythrocyt part gener membran membranebound enzym alter remain determin whether thi alter ca2atpas activ directli relat defect calcium transport cell gener phenomenon cf present cell type directli involv secret